Cargando…

Meta-Analysis of Atrial Fibrillation in Patients With COVID-19

Detalles Bibliográficos
Autores principales:	Yang, Haiyan, Liang, Xuan, Xu, Jie, Hou, Hongjie, Wang, Yadong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839388/ https://www.ncbi.nlm.nih.gov/pubmed/33508269 http://dx.doi.org/10.1016/j.amjcard.2021.01.010

Ejemplares similares

The association between obesity and ICU admission among COVID-19 patients: A meta-analysis of adjusted risk estimates
por: Wang, Ying, et al.
Publicado: (2022)

Lack of significant association between dyslipidemia and COVID-19 mortality
por: Yang, Haiyan, et al.
Publicado: (2021)

The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates
por: Hou, Hongjie, et al.
Publicado: (2021)

An updated meta-analysis on the relationship between obesity and COVID-19 mortality
por: Wang, Yadong, et al.
Publicado: (2021)

Impact of asthma on COVID-19 mortality in the United States: Evidence based on a meta-analysis
por: Han, Xueya, et al.
Publicado: (2022)

Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis
por: Han, Xueya, et al.
Publicado: (2022)

The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

The association between myocardial infarction and COVID-19 related mortality: A meta-analysis based on adjusted effect estimates
por: Li, Shuwen, et al.
Publicado: (2022)

The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates
por: Li, Shuwen, et al.
Publicado: (2022)

Significant association between HIV infection and increased risk of COVID-19 mortality: a meta-analysis based on adjusted effect estimates
por: Han, Xueya, et al.
Publicado: (2022)

The Association of Cerebrovascular Disease with Adverse Outcomes in COVID-19 Patients: A Meta-Analysis Based on Adjusted Effect Estimates
por: Xu, Jie, et al.
Publicado: (2020)

A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
por: Xu, Jie, et al.
Publicado: (2021)

A Meta-Analysis on the Association between Peptic Ulcer Disease and COVID-19 Severity
por: Wang, Ying, et al.
Publicado: (2023)

Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates
por: Zhang, Peihua, et al.
Publicado: (2020)

KCNE1 rs1805127 Polymorphism Increases the Risk of Atrial Fibrillation: A Meta-Analysis of 10 Studies
por: Liang, Chang, et al.
Publicado: (2013)

An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients
por: Wang, Ying, et al.
Publicado: (2021)

Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

Atrial fibrillation in athletes and general population: A systematic review and meta-analysis
por: Li, Xiangdan, et al.
Publicado: (2018)

Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)

Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates
por: Li, Yang, et al.
Publicado: (2021)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

Comorbid asthma decreased the risk for COVID-19 mortality in the United Kingdom: Evidence based on a meta-analysis
por: Shi, Liqin, et al.
Publicado: (2023)

Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis
por: Chen, Ming-yue, et al.
Publicado: (2021)

Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021)

NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis
por: Wang, Ying, et al.
Publicado: (2023)

Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Romiti, Giulio Francesco, et al.
Publicado: (2021)

Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Wang, Xiaoxu, et al.
Publicado: (2021)

Glycemic variability and the risk of atrial fibrillation: a meta-analysis
por: Li, Wei, et al.
Publicado: (2023)

Association of atopic diseases with atrial fibrillation risk: A systematic review and meta-analysis
por: Zeng, Rong, et al.
Publicado: (2022)

Relationship between chronic kidney disease and adverse outcomes of coronavirus disease 2019: a meta-analysis based on adjusted risk estimates
por: Xiao, Wenwei, et al.
Publicado: (2021)

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis
por: Wang, Lu, et al.
Publicado: (2023)

Atrial fibrillation and in-hospital mortality in Covid-19 patients
por: Kotadia, I, et al.
Publicado: (2023)

The pooled prevalence of pulmonary embolism in patients with COVID-19
por: Shi, Li, et al.
Publicado: (2020)

YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis
por: Wang, Qing, et al.
Publicado: (2018)

Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
por: Zhang, Chi, et al.
Publicado: (2022)

Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation
por: Huang, Kang, et al.
Publicado: (2022)

Significant association between ischemic heart disease and elevated risk for COVID-19 mortality: A meta-analysis
por: Zhang, Ruiying, et al.
Publicado: (2022)

Meta‑analysis of the efficacy and safety of nifekalant in the conversion of atrial fibrillation
por: Liu, Peng, et al.
Publicado: (2022)

Bisphosphonates and risk of atrial fibrillation: a meta-analysis
por: Kim, Seo Young, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3vjltat066a2jtk9ij8rg0h8a4